{"cik":1785530,"entityName":"WEREWOLF THERAPEUTICS, INC.","facts":{"dei":{"EntityCommonStockSharesOutstanding":{"label":"Entity Common Stock, Shares Outstanding","description":"Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.","units":{"shares":[{"end":"2021-06-04","val":27567644,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q2I"}]}}},"us-gaap":{"AccountsPayableCurrent":{"label":"Accounts Payable, Current","description":"Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":1021000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":1800000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"AccretionExpense":{"label":"Accretion Expense","description":"Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":0,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":95016000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"AccruedLiabilitiesCurrent":{"label":"Accrued Liabilities, Current","description":"Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":3586000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":2890000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"AccruedProfessionalFeesCurrent":{"label":"Accrued Professional Fees, Current","description":"Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":654000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":832000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"AdditionalPaidInCapital":{"label":"Additional Paid in Capital","description":"Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.","units":{"USD":[{"end":"2020-12-31","val":0,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":0,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock":{"label":"Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock","description":"Amount of decrease (increase) in additional paid in capital (APIC) for the increase in carrying amount of redeemable preferred stock.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":95016000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue":{"label":"APIC, Share-based Payment Arrangement, Increase for Cost Recognition","description":"Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":57000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":539000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"AllocatedShareBasedCompensationExpense":{"label":"Share-based Payment Arrangement, Expense","description":"Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":57000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":539000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount":{"label":"Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount","description":"Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.","units":{"shares":[{"start":"2020-01-01","end":"2020-03-31","val":6753000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":21238000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"Assets":{"label":"Assets","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":96398000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":89436000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"AssetsCurrent":{"label":"Assets, Current","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":92914000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":84865000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"CapitalExpendituresIncurredButNotYetPaid":{"label":"Capital Expenditures Incurred but Not yet Paid","description":"Future cash outflow to pay for purchases of fixed assets that have occurred.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":66000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":130000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"CashAndCashEquivalentsAtCarryingValue":{"label":"Cash and Cash Equivalents, at Carrying Value","description":"Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.","units":{"USD":[{"end":"2020-12-31","val":92570000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":84602000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents":{"label":"Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents","description":"Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.","units":{"USD":[{"end":"2019-12-31","val":18104000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2019Q4I"},{"end":"2020-03-31","val":14256000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1I"},{"end":"2020-12-31","val":92777000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":84900000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect":{"label":"Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect","description":"Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-3848000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-7877000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"CommonStockCapitalSharesReservedForFutureIssuance":{"label":"Common Stock, Capital Shares Reserved for Future Issuance","description":"Aggregate number of common shares reserved for future issuance.","units":{"shares":[{"end":"2020-12-31","val":20398000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":20740000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"CommonStockParOrStatedValuePerShare":{"label":"Common Stock, Par or Stated Value Per Share","description":"Face amount or stated value per share of common stock.","units":{"USD/shares":[{"end":"2020-12-31","val":0.0001,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":0.0001,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"CommonStockSharesAuthorized":{"label":"Common Stock, Shares Authorized","description":"The maximum number of common shares permitted to be issued by an entity's charter and bylaws.","units":{"shares":[{"end":"2020-12-31","val":193500000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":196000000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"CommonStockSharesIssued":{"label":"Common Stock, Shares, Issued","description":"Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.","units":{"shares":[{"end":"2020-12-31","val":1746000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":1760000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"CommonStockSharesOutstanding":{"label":"Common Stock, Shares, Outstanding","description":"Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.","units":{"shares":[{"end":"2020-12-31","val":1746000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":1760000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"CommonStockValue":{"label":"Common Stock, Value, Issued","description":"Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.","units":{"USD":[{"end":"2020-12-31","val":2000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":2000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"Depreciation":{"label":"Depreciation","description":"The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":23000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":39000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"EarningsPerShareBasic":{"label":"Earnings Per Share, Basic","description":"The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.","units":{"USD/shares":[{"start":"2020-01-01","end":"2020-03-31","val":-4.58,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-83.36,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"EarningsPerShareDiluted":{"label":"Earnings Per Share, Diluted","description":"The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.","units":{"USD/shares":[{"start":"2020-01-01","end":"2020-03-31","val":-4.58,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-83.36,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"EmployeeRelatedLiabilitiesCurrent":{"label":"Employee-related Liabilities, Current","description":"Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":990000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":381000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions":{"label":"Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount","description":"Amount of cost to be recognized for option under share-based payment arrangement.","units":{"USD":[{"end":"2021-03-31","val":6200000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"GeneralAndAdministrativeExpense":{"label":"General and Administrative Expense","description":"The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":1131000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":2635000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"IncreaseDecreaseInAccountsPayableTrade":{"label":"Increase (Decrease) in Accounts Payable, Trade","description":"Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":302000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":724000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"IncreaseDecreaseInAccruedLiabilities":{"label":"Increase (Decrease) in Accrued Liabilities","description":"The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-47000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-1331000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"IncreaseDecreaseInOperatingLeaseLiability":{"label":null,"description":null,"units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-71000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-159000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"IncreaseDecreaseInOtherOperatingLiabilities":{"label":"Increase (Decrease) in Other Operating Liabilities","description":"Amount of increase (decrease) in operating liabilities classified as other.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-11000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":50000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets":{"label":"Increase (Decrease) in Prepaid Expense and Other Assets","description":"Amount of increase (decrease) in prepaid expenses, and assets classified as other.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-23000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-81000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"InvestmentIncomeNet":{"label":"Investment Income, Net","description":"Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":67000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":33000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"Liabilities":{"label":"Liabilities","description":"Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.","units":{"USD":[{"end":"2020-12-31","val":7179000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":7092000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"LiabilitiesAndStockholdersEquity":{"label":"Liabilities and Equity","description":"Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.","units":{"USD":[{"end":"2020-12-31","val":96398000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":89436000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"LiabilitiesCurrent":{"label":"Liabilities, Current","description":"Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":5284000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":5409000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"NetCashProvidedByUsedInFinancingActivities":{"label":"Net Cash Provided by (Used in) Financing Activities","description":"Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":0,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-538000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"NetCashProvidedByUsedInInvestingActivities":{"label":"Net Cash Provided by (Used in) Investing Activities","description":"Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-449000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-13000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"NetCashProvidedByUsedInOperatingActivities":{"label":"Net Cash Provided by (Used in) Operating Activities","description":"Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-3399000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-7326000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"NetIncomeLoss":{"label":"Net Income (Loss) Attributable to Parent","description":"The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-3827000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-7435000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"NetIncomeLossAvailableToCommonStockholdersBasic":{"label":"Net Income (Loss) Available to Common Stockholders, Basic","description":"Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-3827000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-102451000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"NetIncomeLossAvailableToCommonStockholdersDiluted":{"label":"Net Income (Loss) Available to Common Stockholders, Diluted","description":"Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-3827000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-102451000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"NonoperatingIncomeExpense":{"label":"Nonoperating Income (Expense)","description":"The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":67000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":17000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"OperatingExpenses":{"label":"Operating Expenses","description":"Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":3894000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":7452000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"OperatingIncomeLoss":{"label":"Operating Income (Loss)","description":"The net result for the period of deducting operating expenses from operating revenues.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-3894000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-7452000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"OperatingLeaseLiabilityCurrent":{"label":"Operating Lease, Liability, Current","description":"Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.","units":{"USD":[{"end":"2020-12-31","val":677000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":699000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"OperatingLeaseLiabilityNoncurrent":{"label":"Operating Lease, Liability, Noncurrent","description":"Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.","units":{"USD":[{"end":"2020-12-31","val":1864000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":1683000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"OperatingLeaseRightOfUseAsset":{"label":"Operating Lease, Right-of-Use Asset","description":"Amount of lessee's right to use underlying asset under operating lease.","units":{"USD":[{"end":"2020-12-31","val":2471000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":2305000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"OperatingLeaseRightOfUseAssetAmortizationExpense":{"label":"Operating Lease, Right-of-Use Asset, Amortization Expense","description":"Amount of amortization expense for right-of-use asset from operating lease.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":152000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":166000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"OtherAccruedLiabilitiesCurrent":{"label":"Other Accrued Liabilities, Current","description":"Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":94000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":388000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"OtherLiabilitiesCurrent":{"label":"Other Liabilities, Current","description":"Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":0,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":20000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"OtherLiabilitiesNoncurrent":{"label":"Other Liabilities, Noncurrent","description":"Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":31000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":0,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"OtherNonoperatingIncomeExpense":{"label":"Other Nonoperating Income (Expense)","description":"Amount of income (expense) related to nonoperating activities, classified as other.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":0,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-16000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"PaymentsOfFinancingCosts":{"label":"Payments of Financing Costs","description":"The cash outflow for loan and debt issuance costs.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":0,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":559000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"PaymentsToAcquirePropertyPlantAndEquipment":{"label":"Payments to Acquire Property, Plant, and Equipment","description":"The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":449000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":13000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"PrepaidExpenseAndOtherAssetsCurrent":{"label":"Prepaid Expense and Other Assets, Current","description":"Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":344000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":263000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"ProceedsFromStockOptionsExercised":{"label":"Proceeds from Stock Options Exercised","description":"Amount of cash inflow from exercise of option under share-based payment arrangement.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":0,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":21000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"PropertyPlantAndEquipmentNet":{"label":"Property, Plant and Equipment, Net","description":"Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.","units":{"USD":[{"end":"2020-12-31","val":651000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":694000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"ResearchAndDevelopmentExpense":{"label":"Research and Development Expense","description":"The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":2763000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":4817000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"RestrictedCashNoncurrent":{"label":"Restricted Cash, Noncurrent","description":"Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.","units":{"USD":[{"end":"2020-12-31","val":207000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":298000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"RetainedEarningsAccumulatedDeficit":{"label":"Retained Earnings (Accumulated Deficit)","description":"The cumulative amount of the reporting entity's undistributed earnings or deficit.","units":{"USD":[{"end":"2020-12-31","val":-51865000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":-153756000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"ShareBasedCompensation":{"label":"Share-based Payment Arrangement, Noncash Expense","description":"Amount of noncash expense for share-based payment arrangement.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":57000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":539000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number","description":"The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.","units":{"shares":[{"end":"2021-03-31","val":54000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price","description":"The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.","units":{"USD/shares":[{"end":"2021-03-31","val":3.25,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value","description":"Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":0,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":100000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period","description":"The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.","units":{"shares":[{"start":"2021-01-01","end":"2021-03-31","val":0,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross","description":"Gross number of share options (or share units) granted during the period.","units":{"shares":[{"start":"2021-01-01","end":"2021-03-31","val":356000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value","description":"The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.","units":{"USD/shares":[{"start":"2020-01-01","end":"2020-03-31","val":1120000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":4230000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number","description":"Number of options outstanding, including both vested and non-vested options.","units":{"shares":[{"end":"2020-12-31","val":2059000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":2402000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price","description":"Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.","units":{"USD/shares":[{"end":"2020-12-31","val":3.79,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":4.16,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price","description":"Weighted average price at which option holders acquired shares when converting their stock options into shares.","units":{"USD/shares":[{"start":"2021-01-01","end":"2021-03-31","val":1.56,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price","description":"Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.","units":{"USD/shares":[{"start":"2021-01-01","end":"2021-03-31","val":0,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price","description":"Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.","units":{"USD/shares":[{"start":"2021-01-01","end":"2021-03-31","val":6.22,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"StockholdersEquity":{"label":"Stockholders' Equity Attributable to Parent","description":"Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.","units":{"USD":[{"end":"2019-12-31","val":-24304000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2019Q4I"},{"end":"2020-03-31","val":-28074000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1I"},{"end":"2020-12-31","val":-51863000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":-153754000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1I"}]}},"StockIssuedDuringPeriodSharesStockOptionsExercised":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period","description":"Number of share options (or share units) exercised during the current period.","units":{"shares":[{"start":"2021-01-01","end":"2021-03-31","val":13000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"StockIssuedDuringPeriodValueStockOptionsExercised":{"label":"Stock Issued During Period, Value, Stock Options Exercised","description":"Value of stock issued as a result of the exercise of stock options.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":21000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"TemporaryEquityAccretionToRedemptionValueAdjustment":{"label":"Temporary Equity, Accretion to Redemption Value, Adjustment","description":"Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":0,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":95016000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"TemporaryEquitySharesIssued":{"label":"Temporary Equity, Shares Issued","description":"The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.","units":{"shares":[{"end":"2019-12-31","val":48675140,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2019Q4I"}]}},"WarrantsAndRightsOutstanding":{"label":"Warrants and Rights Outstanding","description":"Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.","units":{"USD":[{"end":"2019-12-30","val":7800000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10"},{"end":"2019-12-31","val":7300000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2019Q4I"},{"end":"2020-06-01","val":7800000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q2I"}]}},"WeightedAverageNumberOfDilutedSharesOutstanding":{"label":"Weighted Average Number of Shares Outstanding, Diluted","description":"The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.","units":{"shares":[{"start":"2020-01-01","end":"2020-03-31","val":836000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":1229000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}},"WeightedAverageNumberOfSharesOutstandingBasic":{"label":"Weighted Average Number of Shares Outstanding, Basic","description":"Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.","units":{"shares":[{"start":"2020-01-01","end":"2020-03-31","val":836000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":1229000,"accn":"0001785530-21-000026","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-06-10","frame":"CY2021Q1"}]}}}}}